Teva Will Appeal Loss In Vigamox Eyecare Patent Suit

Law360, New York (November 20, 2009, 12:55 PM EST) -- Teva Pharmaceuticals USA Inc., having come out on the losing end in a three-year infringement struggle with Alcon Inc. over a patent related to the anti-bacterial eye drop drug Vigamox, has said it will keep up the fight in an appeal to the U.S. Court of Appeals for the Federal Circuit.

Judge Sue L. Robinson of the U.S. District Court for the District of Delaware entered final judgment against the U.S. arm of the Israel-based generics maker Oct. 20 after ruling that Teva's generic product infringed...
To view the full article, register now.